Twist Bioscience (TWST) Price to Sales (2018 - 2026)

Twist Bioscience (TWST) has reported Price to Sales for 9 consecutive years, with 54.47 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales rose 136.34% year-over-year to 54.47 in Q2 2026; TTM through Jun 2026 was 14.93, a 144.36% increase from a year earlier, with the FY2025 full-year figure at 4.53, down 46.69% from the prior year.
• Price to Sales was 54.47 for Q2 2026 at Twist Bioscience, up from 26.68 in the prior quarter.
• Over five years, Price to Sales peaked at 57.7 in Q1 2022 and troughed at 14.31 in Q1 2023.
• A 5-year average of 29.02 and a median of 26.59 in 2024 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales sank 81.27% in 2022 and surged 136.34% in 2026, its largest moves.
• Over 5 years, Price to Sales stood at 24.86 in 2022, then grew by 19.8% to 29.79 in 2023, then gained by 4.78% to 31.21 in 2024, then tumbled by 39.95% to 18.74 in 2025, then soared by 190.61% to 54.47 in 2026.
• The last three Price to Sales figures came in at 54.47 (Q2 2026), 26.68 (Q1 2026), and 18.74 (Q4 2025), per Business Quant data.